Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Share-based Compensation (2016 - 2026)

Biomerica's Share-based Compensation history spans 16 years, with the latest figure at $58000.0 for Q1 2026.

  • Quarterly results put Share-based Compensation at $58000.0 for Q1 2026, down 36.26% from a year ago — trailing twelve months through Feb 2026 was $371000.0 (down 29.6% YoY), and the annual figure for FY2025 was $460000.0, down 45.04%.
  • Share-based Compensation for Q1 2026 was $58000.0 at Biomerica, down from $72000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $384000.0 in Q1 2023 to a low of $58000.0 in Q1 2026.
  • The 5-year median for Share-based Compensation is $170000.0 (2023), against an average of $196528.3.
  • The sharpest move saw Share-based Compensation surged 1212.59% in 2022, then crashed 73.24% in 2025.
  • Year by year, Share-based Compensation stood at $318000.0 in 2022, then tumbled by 61.64% to $122000.0 in 2023, then grew by 27.05% to $155000.0 in 2024, then tumbled by 53.55% to $72000.0 in 2025, then decreased by 19.44% to $58000.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $58000.0, $72000.0, and $133000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.